Investors Land BTAI Even Cheaper Than Its Secondary Stock Offering
June 25, 2021 at 10:33 AM EDT
Looking back to 2 days ago, BioXcel Therapeutics Inc (BTAI) priced a 3,155,000 share secondary stock offering at $31.70 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..